|
|
|
|
Departments of Psychiatry (I.O., M.L.A., H.K.K., N.A-T., J.M.H., E.J.S.) and Pharmacology (E.J.S.), New York University School of Medicine, New York, New York
The carboxyl tail of the human µ opioid receptor was shown to bind the carboxyl terminal region of human filamin A, a protein known to couple membrane proteins to actin. Results from yeast two-hybrid screening were confirmed by direct protein-protein binding and by coimmunoprecipitation of filamin and µ opioid receptor from cell lysates. To investigate the role of filamin A in opioid receptor function and regulation, we used the melanoma cell line M2, which does not express filamin A, and its subclone A7, transfected with human filamin A cDNA. Both cell lines were stably transfected with cDNA encoding myc-tagged human µ opioid receptor. Fluorescent studies, using confocal microscopy, provided evidence that filamin and µ opioid receptors were extensively colocalized on the membranes of filamin-expressing melanoma cells. The immunostaining of µ opioid receptors indicated that the lack of filamin had no detectable effect on membrane localization of the receptors. Moreover, µ opioid receptors function normally in the absence of filamin A, as evidenced by studies of opioid binding and DAMGO inhibition of forskolin-stimulated adenylyl cyclase. However, agonist-induced receptor down-regulation and functional desensitization were virtually abolished in cells lacking filamin A. The level of internalized µ-opioid receptors, after 30-min exposure to agonist, was greatly reduced, suggesting a role for filamin in µ opioid receptor trafficking. During these studies, we observed that forskolin activation of adenylyl cyclase was greatly reduced in filamin-lacking cells. An even more unexpected finding was the ability of long-term treatment with [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin of M2 cells, containing µ opioid receptors, to restore normal forskolin activation. The mechanism of this effect is currently unknown. It is postulated that the observed effects on µ opioid receptor regulation by filamin A and, by implication, of the actin cytoskeleton may be the result of its role in µ opioid receptor trafficking.
This article has been cited by other articles:
![]() |
J. L. Fiori, T.-N. Zhu, M. P. O'Connell, K. S. Hoek, F. E. Indig, B. P. Frank, C. Morris, S. Kole, J. Hasskamp, G. Elias, et al. Filamin A Modulates Kinase Activation and Intracellular Trafficking of Epidermal Growth Factor Receptors in Human Melanoma Cells Endocrinology, June 1, 2009; 150(6): 2551 - 2560. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Beekman, C. E. van der Poel, J. A. van der Linden, D. L. C. van den Berg, P. V. E. van den Berghe, J. G. J. van de Winkel, and J. H. W. Leusen Filamin A Stabilizes Fc{gamma}RI Surface Expression and Prevents Its Lysosomal Routing J. Immunol., March 15, 2008; 180(6): 3938 - 3945. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-Y. Cho, D.-I. Cho, J. H. Park, H. Kurose, M. G. Caron, and K.-M. Kim Roles of Protein Kinase C and Actin-Binding Protein 280 in the Regulation of Intracellular Trafficking of Dopamine D3 Receptor Mol. Endocrinol., September 1, 2007; 21(9): 2242 - 2254. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Kim, L. D. Ridgway, and S. E. Dryer Interactions with Filamin A Stimulate Surface Expression of Large-Conductance Ca2+-Activated K+ Channels in the Absence of Direct Actin Binding Mol. Pharmacol., September 1, 2007; 72(3): 622 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-F. Wu, T. Koch, Y.-J. Liang, R. Stumm, S. Schulz, H. Schroder, and V. Hollt Membrane Glycoprotein M6a Interacts with the {micro}-Opioid Receptor and Facilitates Receptor Endocytosis and Recycling J. Biol. Chem., July 27, 2007; 282(30): 22239 - 22247. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Daulat, P. Maurice, C. Froment, J.-L. Guillaume, C. Broussard, B. Monsarrat, P. Delagrange, and R. Jockers Purification and Identification of G Protein-coupled Receptor Protein Complexes under Native Conditions Mol. Cell. Proteomics, May 1, 2007; 6(5): 835 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cabello, R. Remelli, L. Canela, A. Soriguera, J. Mallol, E. I. Canela, M. J. Robbins, C. Lluis, R. Franco, R. A. J. McIlhinney, et al. Actin-binding Protein {alpha}-Actinin-1 Interacts with the Metabotropic Glutamate Receptor Type 5b and Modulates the Cell Surface Expression and Function of the Receptor J. Biol. Chem., April 20, 2007; 282(16): 12143 - 12153. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liao, O. O. Grigoriants, H. H. Loh, and P.-Y. Law Agonist-Dependent Postsynaptic Effects of Opioids on Miniature Excitatory Postsynaptic Currents in Cultured Hippocampal Neurons J Neurophysiol, February 1, 2007; 97(2): 1485 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Liang, D.-F. Wu, L.-Q. Yang, V. Hollt, and T. Koch Interaction of the {micro}-Opioid Receptor with Synaptophysin Influences Receptor Trafficking and Signaling Mol. Pharmacol., January 1, 2007; 71(1): 123 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. H. Scott, V. Pierotti, H. Storez, E. Lindberg, A. Thuret, O. Muntaner, C. Labbe-Jullie, J. A. Pitcher, and S. Marullo Cooperative Regulation of Extracellular Signal-Regulated Kinase Activation and Cell Shape Change by Filamin A and {beta}-Arrestins. Mol. Cell. Biol., May 1, 2006; 26(9): 3432 - 3445. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Talbot, H. K. Happe, and L. C. Murrin {micro} Opioid Receptor Coupling to Gi/o Proteins Increases during Postnatal Development in Rat Brain J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 596 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Kim, R. R. Gainetdinov, S. A. Laporte, M. G. Caron, and L. S. Barak G Protein-coupled Receptor Kinase Regulates Dopamine D3 Receptor Signaling by Modulating the Stability of a Receptor-Filamin-{beta}-Arrestin Complex: A CASE OF AUTORECEPTOR REGULATION J. Biol. Chem., April 1, 2005; 280(13): 12774 - 12780. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang and G. E. Breitwieser High Affinity Interaction with Filamin A Protects against Calcium-sensing Receptor Degradation J. Biol. Chem., March 25, 2005; 280(12): 11140 - 11146. [Abstract] [Full Text] [PDF] |
||||